Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Takehiro Takahashi
Affiliation
Yale University School of Medicine
ORCID
Career Start Year
2011
Papers
98
H Index
27
Expertise
CM4AI Collaborator
Wade Schulz (CM4AI)
PMID
Paper Title
Journal Title
Published Year
33479140
Sex differences in immune responses.
Science
2021
32232898
Clinical significance of endothelial vasodilatory function evaluated by EndoPAT in patients with systemic sclerosis.
J Dermatol
2020
31782787
Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis.
Rheumatology (Oxford)
2020
31959382
Regulation of skin fibrosis by RALDH1-producing dermal dendritic cells via retinoic acid-mediated regulatory T cell induction: A role in scleroderma.
J Dermatol Sci
2020
32577695
Sex differences in immune responses to SARS-CoV-2 that underlie disease outcomes.
medRxiv
2020
32627966
Altered Properties of Endothelial Cells and Mesenchymal Stem Cells Underlying the Development of Scleroderma-like Vasculopathy in KLF5<sup>+/-</sup> ;Fli-1<sup>+/-</sup> Mice.
Arthritis Rheumatol
2020
32846427
Sex differences in immune responses that underlie COVID-19 disease outcomes.
Nature
2020
30520152
A potential contribution of trappin-2 to the development of vasculopathy in systemic sclerosis.
J Eur Acad Dermatol Venereol
2019
30168849
Assessment of endothelial function during the loading phase of infliximab in psoriasis: a potential predictor of its drug survival.
Int J Dermatol
2019
31502326
Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti-topoisomerase I-positive systemic sclerosis-associated interstitial lung disease.
J Dermatol
2019
30858571
Aedes aegypti AgBR1 antibodies modulate early Zika virus infection of mice.
Nat Microbiol
2019
31079997
Systemic sclerosis: Is the epithelium a missing piece of the pathogenic puzzle?
J Dermatol Sci
2019
30270117
Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis.
J Dermatol Sci
2019
28681537
A potential contribution of psoriasin to vascular and epithelial abnormalities and inflammation in systemic sclerosis.
J Eur Acad Dermatol Venereol
2018
29947047
CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis.
Exp Dermatol
2018
30268392
Progranulin overproduction due to constitutively activated c-Abl/PKC-δ/Fli1 pathway contributes to the resistance of dermal fibroblasts to the anti-fibrotic effect of tumor necrosis factor-α in localized scleroderma.
J Dermatol Sci
2018
30289572
Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study.
J Dermatol
2018
29415756
Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells.
Arthritis Res Ther
2018
29279288
Systemic sclerosis complicated with localized scleroderma-like lesions induced by Köbner phenomenon.
J Dermatol Sci
2018
29044628
Possible pro-inflammatory role of heparin-binding epidermal growth factor-like growth factor in the active phase of systemic sclerosis.
J Dermatol
2018
29265579
Successful treatment with rituximab in a Japanese patient with systemic sclerosis-associated interstitial lung disease resistant to oral steroid and cyclophosphamide.
J Dermatol
2018
27538472
Plasma plasmin-α2-plasmin inhibitor complex levels may predict the effect of cyclophosphamide for systemic sclerosis-related interstitial lung disease.
Mod Rheumatol
2017
28389593
CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells.
J Immunol
2017
28232470
Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma.
J Exp Med
2017
28432700
Serum H-ficolin levels: Clinical association with interstitial lung disease in patients with systemic sclerosis.
J Dermatol
2017
28497874
Serum angiopoietin-2 level as a potential biomarker in psoriasis vulgaris.
J Dermatol
2017
28378437
Serum LL-37 levels correlate with the efficacy of i.v. cyclophosphamide pulse for skin sclerosis and interstitial lung disease in systemic sclerosis.
J Dermatol
2017
28370536
The impact of transcription factor Fli1 deficiency on the regulation of angiogenesis.
Exp Dermatol
2017
29038846
A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis.
Arch Dermatol Res
2017
28507181
Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis.
J Rheumatol
2017
28528914
Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency.
J Invest Dermatol
2017
27900875
Unprecedented success of rituximab therapy for prednisolone- and immunosuppressant-resistant systemic sclerosis-associated interstitial lung disease.
Scand J Rheumatol
2017
27777101
Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.
J Invest Dermatol
2017
28026802
Ethosuximide-induced lupus-scleroderma syndrome with disease-specific autoantibodies.
Eur J Dermatol
2017
24499427
A case of scleredema adultorum successfully treated with narrow-band ultraviolet B phototherapy.
Mod Rheumatol
2016
26661692
A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis.
Exp Dermatol
2016
26567180
Nucleosome in patients with systemic sclerosis: possible association with immunological abnormalities via abnormal activation of T and B cells.
Ann Rheum Dis
2016
26399195
Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions.
Br J Dermatol
2016
27129435
Linear scleroderma with prominent multiple lymphadenopathy followed by the development of polymyositis: A case report and review of published work.
J Dermatol
2016
26967475
Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune Cells.
J Invest Dermatol
2016
26777734
Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis.
J Dermatol
2016
27086491
The development of chronic inflammatory demyelinating polyneuropathy during adalimumab treatment in a patient with psoriasis vulgaris.
Eur J Dermatol
2016
26825047
Decreased interleukin-21 expression in skin and blood in advanced mycosis fungoides.
J Dermatol
2016
26876001
Association of anti-RNA polymerase III antibody and silicone breast implants in patients with systemic sclerosis.
J Dermatol
2016
27105895
A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis.
Br J Dermatol
2016
26727543
The first case report of fatal acute pulmonary dysfunction in a systemic sclerosis patient treated with rituximab.
Scand J Rheumatol
2016
26173737
Scleroderma en coup de sabre with recurrent episodes of brain hemorrhage.
J Dermatol
2016
25976154
Serum IL-33 levels are increased in patients with psoriasis.
Clin Exp Dermatol
2016
24517166
Circulating galectin-1 concentrations in systemic sclerosis: potential contribution to digital vasculopathy.
Int J Rheum Dis
2016
24593173
Effect of ambrisentan on peripheral circulation in patients with systemic sclerosis.
Mod Rheumatol
2016
1 - 50 of 98
Column Actions
Search
Recommended Authors
Charlotte Hurabielle
University of California san francisco
Career Start Year
2014
Number of shared co-authors
0
Hiromitsu Asashima
Institute of Medicine, University of Tsukuba
Career Start Year
2011
Number of shared co-authors
13
Beatrice Dyring-Andersen
Herlev and Gentofte Hospital, University of Copenhagen
Career Start Year
2011
Number of shared co-authors
0
Zareen Ahmad
Mount Sinai Hospital.
Career Start Year
2011
Number of shared co-authors
0
Viktor Martyanov
Geisel School of Medicine at Dartmouth
Career Start Year
2010
Number of shared co-authors
0
Lara Bossini-Castillo
Departamento de Genetica e Instituto de Biotecnologia, Universidad de Granada
Career Start Year
2010
Number of shared co-authors
0
Carolina Mu??oz-Grajales
Schroeder Arthritis Institute, Krembil Research Institute, University Health Network
Career Start Year
2009
Number of shared co-authors
0
Tammara A Wood
Geisel School of Medicine at Dartmouth
Career Start Year
2008
Number of shared co-authors
0
Rajaie Namas
Medical Subspecialities Institute, Cleveland Clinic
Career Start Year
2008
Number of shared co-authors
0
Monique Hinchcliff
Yale School of Medicine
Career Start Year
2007
Number of shared co-authors
2
Yihong Yao
Cellular Biomedicine Group Inc.
Career Start Year
2005
Number of shared co-authors
0
Sindhu R Johnson
Toronto Western Hospital, University of Toronto
Career Start Year
2003
Number of shared co-authors
0
Yi Li
Beth Israel Deaconess Hospital
Career Start Year
2003
Number of shared co-authors
0
Lorenzo Beretta
Scleroderma Clinic, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year
2001
Number of shared co-authors
0
Edward W Cowen
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Career Start Year
1999
Number of shared co-authors
0
Shinsuke Yasuda
Tokyo Medical and Dental University
Career Start Year
1998
Number of shared co-authors
0
Xinping Tian
Peking Union Medical College Hospital (PUMCH)
Career Start Year
1998
Number of shared co-authors
0
Hanno B Richards
Novartis Pharma AG
Career Start Year
1995
Number of shared co-authors
0
Michael L Whitfield
Geisel School of Medicine at Dartmouth
Career Start Year
1995
Number of shared co-authors
0
Barbara White
Corbus Pharmaceuticals Holdings
Career Start Year
1994
Number of shared co-authors
0
Ling-Ying Lu
Kaohsiung Veterans General Hospital
Career Start Year
1992
Number of shared co-authors
0
Clay B Marsh
West Virginia University School of Medicine
Career Start Year
1992
Number of shared co-authors
0
Isabelle Marie
Centre Hospitalo-Universitaire de Rouen
Career Start Year
1988
Number of shared co-authors
0
Antony Rosen
Johns Hopkins University
Career Start Year
1988
Number of shared co-authors
0
Minoru Satoh
University of Occupational and Environmental Health
Career Start Year
1986
Number of shared co-authors
0
Chaim Putterman
Albert Einstein College of Medicine
Career Start Year
1986
Number of shared co-authors
0
Maureen D Mayes
University of Texas McGovern Medical School
Career Start Year
1985
Number of shared co-authors
0
John D Reveille
University of Texas
Career Start Year
1983
Number of shared co-authors
0
Arthur Bookman
University of Toronto
Career Start Year
1976
Number of shared co-authors
0
Dafna D Gladman
Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital
Career Start Year
1975
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Akiko Iwasaki
Yale University
Co-authored papers
4
Issei Komuro
Co-authored papers
4
Saad B Omer
Yale School of Public Health
Co-authored papers
2
Benjamin Israelow
Yale University School of Medicine
Co-authored papers
2
Maria Tokuyama
Yale University School of Medicine
Co-authored papers
2
Aaron M Ring
Yale University School of Medicine
Co-authored papers
2
Patrick Wong
Yale School of Medicine
Co-authored papers
2
Albert I Ko
Instituto Goncalo Moniz, Yale School of Public Health
Co-authored papers
2
Arnau Casanovas-Massana
School of Public Health, Yale University
Co-authored papers
2
Peiwen Lu
Yale University School of Medicine
Co-authored papers
2
Arvind Venkataraman
Christian Medical College
Co-authored papers
2
Mallory K Ellingson
Yale University School of Public Health, 60 College St
Co-authored papers
2
Chantal B F Vogels
Yale School of Public Health
Co-authored papers
2
Anne L Wyllie
Yale School of Public Health
Co-authored papers
2
Carolina Lucas
Yale School of Medicine
Co-authored papers
2
Adam J Moore
Yale School of Public Health
Co-authored papers
2
Amit Meir
Boyer Center for Molecular Medicine, Yale University
Co-authored papers
2
Charles S Dela Cruz
Department of Microbial Pathogenesis Yale University New Haven
Co-authored papers
2
Isabel M Ott
Yale School of Public Health
Co-authored papers
2
Tianyang Mao
Yale University School of Medicine
Co-authored papers
2
Nathan D Grubaugh
Yale School of Public Health
Co-authored papers
2
Shelli F Farhadian
Yale School of Medicine
Co-authored papers
2
Ji Eun Oh
College of Science & Industry Convergence, Ewha Womans University
Co-authored papers
2
Annsea Park
Yale University School of Medicine
Co-authored papers
1
Feimei Liu
Yale University School of Medicine
Co-authored papers
1
Jonathan Sun
Yale University School of Medicine
Co-authored papers
1
David A Hafler
Yale School of Medicine, Yale School of Public Health
Co-authored papers
1
Sarah Lapidus
Yale School of Public Health
Co-authored papers
1
Wade Schulz (CM4AI)
Yale University
Co-authored papers
1
Albert C Shaw
Yale School of Medicine, Yale University
Co-authored papers
1
1 - 30